Services
Solutions
About Us
Resources
AAV IND-enabling CMC services from plasmid to GMP - ProBio CDMO

AAV IND-Enabling CMC

An end-to-end AAV vector CDMO solution that supports gene therapy developers from early development through GMP manufacturing and regulatory submission.

Plasmid to GMP-Grade AAV in 8 Months

AAV IND-enabling CMC workflow Plasmid to GMP-grade AAV in 8 Months, showing development stages and the manufacturing workflow from Cell Thawing through QC Release. PackingTestDemo Run CellBanking ProcessDevelopment Verification RunEngineeringRun AnalyticalDevelopment GMPManufacturing Stability TestRegulatorySupport To evaluatethe titer andfunction ofAAV Small scaleproductionevaluation •  MCB/WCBConstruction•  Cell BankCharacterization•  Cell BankStability Test •  UpstreamProcessDevelopment•  DownstreamProcessDevelopment•  FormulationProcessDevelopment •  Verification run•  QC and release •  Full scale inclean room,used fortoxicologybatch•  QC and release •  AnalyticalMethodDevelopment•  AnalyticalMethodQualification •  GMPManufacturing•  Quality Controland Release •  AcceleratedStability Test•  InfluencingFactor StabilityTest•  Long-termStability Test •  Report anddocumentpreparationfor regulatoryfiling CellThawingCellExpansion TransfectionLysis andNucleaseClarification PurificationConcentrationBufferExchange SterilizationDS StorageQC Release FormulationSterilizationFill &Finish QCRelease
Case study: High-titer AAV production across multiple serotypes with PowerS™-293
Case study: PowerS™-293 cell density and viability for scalable AAV manufacturing
Resource flyer: GMP AAV plasmid manufacturing for IND-enabling studies
Resource poster: Rapid GMP-grade AAV6 manufacturing platform
Resource flyer: GMP viral vector manufacturing for pre-clinical and clinical use
Resource poster: PowerS™-ITRrs strain performance for AAV transfer plasmids
Request a quote for AAV IND-enabling CMC services - ProBio

Request a Quote

Begin your journey with AAV manufacturing for GMP.

Frequently Asked Questions